Two beautiful provinces, each in their own unique way, but two provinces where there is less than ideal drug coverage for kidney cancer patients…
First to New Brunswick
This week we will be meeting with rcc physicians in New Brunswick to outline the challenges faced by patients in that province. New Brunswick patients are in a particularly tough situation. Not only do they have no access to Torisel in the first line, or anything whatsoever after standard first-line treatment, they are also one of only two provinces to offer no catastrophic drug coverage whatsoever. (The other is PEI). We’ve requested meetings with the NB Health Minister and NB Drug Plan Manager to discuss what can be done. In the meantime, we hope to win over the hearts and minds of treating oncologists and nurses to get their patients in touch with KCC.
Then on to St. John’s NL
Newfoundland and Labrador has historically fared well in Atlantic Canada for mrcc, but unfortunately there is still nothing offered to patients who progress on Sutent. We’ll be meeting with the NLPDP Drug Plan Managers to outline the case for sequential treatment. Without something in place, patients in Newfoundland and Labrador will have to pay out of pocket $6,000 per month for second-line treatment that would be covered if only they lived in BC, AB, SK, or ON.
Join the Fight
If you live in either of these beautiful provinces, please get in touch with your MLA and let them know that “last in Canada” is not good enough for you. You’ll find sample letters customized for each province on our website under “Join the Fight”.
We’re Joining the Fight with you. Wish us luck!